A simple, sensitive and reproducible spectrophotometric method was developed for the determination of aripiprazole in pure form and in pharmaceutical formulation. It has an absorption maximum at 219 nm and obeys beer's law in the concentration range 2- 10 µg mL-1. Results of analysis were validated statistically and by recovery studies. The apparent molar absorptivity and sandell's sensitivity were 5.2 x 105L mol-1cm-1and 8.4 x 10-3µg cm-2, respectively. The slope and intercept of the equation of the regression line are 0.0035 and 0.1155 respectively. Correlation coefficient was found to be 0.9998. This method is successfully employed for the determination of aripiprazole in pharmaceutical preparation.

A simple, accurate, specific reverse-phase, high-performance liquid chromatography method has been developed for the determination of sorafenib tosylate in its pure form and its tablets. In this method, sorafenib tosylate was eluted by isocratic mode using a Phenomenex Luna C18 column by a mobile phase composition of acetonitrile and water in the ratio of 82.5 : 17.5, v/v. The flow rate was 1.5 mL/min. The eluted drug was monitored at 265 nm and the method was found to be linear from 5 to 80 μg/mL. The method was validated by linearity, precision, accuracy, LOD, and LOQ. The accuracy report denotes that there is not any interference of additives used in the formulation.

Thiazole and imidazole derivatives have attracted medicinal chemists owing to their extensive biological activities. Present paper describes the synthesis of some new thiazolo imidazole derivatives. 4-Substituted phenacyl bromides were prepared from substituted acetophenones. The products were condensed with thiourea to obtain 2-amino-4-(4-substituted phenyl)thiazoles which on further reaction with 4-substituted phenacyl bromides resulted in 3,6-di(substituted phenyl)imidazo[2,1-b] thiazoles (3a-3i). The formation of all the compounds was established by spectral techniques like IR, 1 H NMR and Mass spectral data. The title compounds were screened for their antimicrobial activity against Gram-positive bacteria S. aureus and B. subtilis, Gram-negative bacteria E. coli and K. pneumoniae and the fungal strains like A. niger, C. albicans and C. neoformans. The results indicated that the compounds coded 3a, 3c, 3g and 3i showed significant activity than the remaining compounds.

Review: 26 refs.

No abstract